Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Clinical management of the cardiovascular failure in sepsis.

De Backer D, Scolletta S.

Curr Vasc Pharmacol. 2013 Mar 1;11(2):222-42. Review.

PMID:
23506500
2.

[New inotropic agents in the treatment of congestive heart failure].

Freitas M.

Rev Port Cardiol. 1993 Nov;12 Suppl 4:19-28, 7-8. Review. Portuguese.

PMID:
7904458
3.

Adrenergic support in septic shock: a critical review.

Póvoa P, Carneiro AH.

Hosp Pract (1995). 2010 Feb;38(1):62-73. Review.

PMID:
20469626
4.

Haemodynamic management of a patient with septic shock.

Reinhart K, Sakka SG, Meier-Hellmann A.

Eur J Anaesthesiol. 2000 Jan;17(1):6-17. Review.

PMID:
10758438
5.

Is it time to reposition vasopressors and inotropes in sepsis?

Rudis MI, Basha MA, Zarowitz BJ.

Crit Care Med. 1996 Mar;24(3):525-37. Review.

PMID:
8625645
6.

The heart in sepsis: from basic mechanisms to clinical management.

Rudiger A, Singer M.

Curr Vasc Pharmacol. 2013 Mar 1;11(2):187-95. Review.

7.

[Use of new inotropic agents in the treatment of acute cardiac failure].

Dhainaut JF.

Ann Fr Anesth Reanim. 1988;7(2):97-104. French.

PMID:
2896479
8.

Vasopressors and Inotropes in Sepsis.

Stratton L, Berlin DA, Arbo JE.

Emerg Med Clin North Am. 2017 Feb;35(1):75-91. doi: 10.1016/j.emc.2016.09.005. Review.

PMID:
27908339
9.
10.

Heart failure in pediatric septic shock: utilizing inotropic support.

Tabbutt S.

Crit Care Med. 2001 Oct;29(10 Suppl):S231-6. Review.

PMID:
11593066
11.

Increased contribution of alpha 1- vs. beta-adrenoceptor-mediated inotropic response in rats with congestive heart failure.

Sjaastad I, Schiander I, Sjetnan A, Qvigstad E, Bøkenes J, Sandnes D, Osnes JB, Sejersted OM, Skomedal T.

Acta Physiol Scand. 2003 Apr;177(4):449-58.

PMID:
12648162
12.

Vasopressin in sepsis and septic shock.

Kampmeier TG, Rehberg S, Westphal M, Lange M.

Minerva Anestesiol. 2010 Oct;76(10):844-50. Review.

13.

Pharmacologic treatment of heart failure due to ventricular dysfunction by myocardial stunning: potential role of levosimendan.

García González MJ, Domínguez Rodríguez A.

Am J Cardiovasc Drugs. 2006;6(2):69-75. Review.

PMID:
16555860
14.

Vasoactive drugs for vasodilatory shock in ICU.

Holmes CL, Walley KR.

Curr Opin Crit Care. 2009 Oct;15(5):398-402. doi: 10.1097/MCC.0b013e32832e96ef. Review.

PMID:
19542884
15.

Perioperative treatment of patients with sepsis.

Ibsen M, Perner A.

Curr Opin Anaesthesiol. 2013 Jun;26(3):348-53. doi: 10.1097/ACO.0b013e32835fb6ee. Review.

PMID:
23474806
16.

Treatment of shock.

De Backer D.

Acta Clin Belg. 2011 Nov-Dec;66(6):438-42. Review.

PMID:
22338308
17.

Effects of catecholamines on regional perfusion and oxygenation in critically ill patients.

Meier-Hellmann A, Reinhart K.

Acta Anaesthesiol Scand Suppl. 1995;107:239-48. Review.

PMID:
8599285
18.

Vasoactive drugs and the gut: is there anything new?

Woolsey CA, Coopersmith CM.

Curr Opin Crit Care. 2006 Apr;12(2):155-9. Review.

PMID:
16543793
19.
20.

Vasopressors in shock: too early to move away from catecholamines?

De Backer D, Scolletta S.

Br J Pharmacol. 2012 Apr;165(7):2012-4. doi: 10.1111/j.1476-5381.2011.01746.x.

Supplemental Content

Support Center